Shanghai, Shanghai
Shuyan Li, PhD, Attending physician of Department of Radiation Oncology, Ruijin Hospital, Shanghai JiaotongUniversity School of Medicine, Shanghai, China
Disclosures:
3025 - The Addition of Pembrolizumab to Neoadjuvant Chemoradiotherapy and the Risk of Developing Postoperative Anastomotic Leakage for ESCC: An Analysis from a Prospective Cohort
Tuesday, October 1, 202412:45 PM – 2:00 PM ET